Everolimus-Eluting Stent (Espalier) in Coronary Artery Revascularization: A Retrospective, Investigator-Initiated, Multicenter Study
Parminder Singh Manghera, Gaurav Mohan, Amit Kumar, Harpreet Singh Gilhotra, Sushil Sharma, Deepti Goel, Roma Tiwari · 2026
Read Everolimus-Eluting Stent (Espalier) in Coronary Artery Revascularization: A Retrospective, Investigator-Initiated, Multicenter Study by Parminder Singh Manghera, Gaurav Mohan, Amit Kumar, Harpreet Singh Gilhotra, Sushil Sharma, Deepti Goel, Roma Tiwari (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13278689.txt.
Description
Parminder Singh Manghera and colleagues report real-world results for an everolimus-eluting heart stent in a 2026 multicentre study. Drug-eluting stents prop open narrowed coronary arteries during angioplasty. The Espalier stent, made in India, was assessed for safety and performance in routine practice.
Records covered 402 adults treated at tertiary centres, followed for twelve months. Device placement and the overall procedure succeeded in every case. Serious target-lesion events stayed rare at one year, and no heart attacks or stent clots occurred. Older patients and those with unstable symptoms or multiple conditions ran higher risks. The authors present the device as effective in everyday Indian practice.
Catalog record
| CREATOR | Parminder Singh Manghera, Gaurav Mohan, Amit Kumar, Harpreet Singh Gilhotra, Sushil Sharma, Deepti Goel, Roma Tiwari |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |